ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1114

Role of Dual-energy Computed Tomography (DECT) in Detection of Carotid Artery Monosodium Urate Deposition in Patients with Gout

Muhammad Danish Sarfraz, Lee Treanor, Savvas Nicolaou and Adnan Sheikh, University of British Columbia, Vancouver, BC, Canada

Meeting: ACR Convergence 2023

Keywords: Carotid Artery Disease, Computed tomography (CT), gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1100–1123) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: To find out if a Dual energy CT can detect monosodium urate deposition in carotid arteries and whether the presence of monosodium urate crystals has any effect on atherosclerotic disease in terms of plaque volume.

Methods: This is a retrospective study. All patients who underwent any Dual energy neck imaging (like carotid angiogram, neck soft tissues or cervical spine) from January 2015 to December 2022 were included. All patients’ charts were reviewed to determine to find gout patients with clinical and laboratory evidence. Charts were also rigorously reviewed to find potential confounding variables like hypertension, dyslipidemia, CKD and smoking as these may have effect on plaque volume. Patients with a smoking history were excluded as it has a well-established role in atherosclerotic disease. Non-smokers with either hypertension, dyslipidemia, CKD or either of two were included as most of the patients have similar comorbidities. Comprehensive data extraction was done to allow multivariable regression analysis for confounding variables. Same number of healthy controls (without a clinical history of gout or other rheumatic diseases) were included during same study period which were then age (within 5 years), sex and confounders-matched to gout patients using MedCalc. Patients with any extensive artefacts, spinal metal implants, carotid stents, carotid endarterectomy prior to scan date or prior radiotherapy to the head and neck were excluded. DECT datasets were post-processed using Syngo.ViaVB30 with gout application class at default factory settings including a DECT iodine ratio of 1.27, minimum HU at 130, resolution of 3mm, and air distance 5. Volumetric analysis of atherosclerotic plaque was performed using Syngo.ViaVB30 with Calcium scoring application in matched gout patients with carotid monosodium deposition, gout patients without carotid monosodium deposition and control/non-gout patients.

Results: Out of total 2157 patients who underwent dual energy neck imaging during study period, 85 were established gout cases with confirmed clinical and laboratory evidence. Of 85 gout cases, 2 were excluded due to presence of streak artefacts from dentures hence, n=83. Out of 83, Monosodium urate deposition was detected in carotid arteries of 10 patients (12%). None of the matched control patient demonstrated monosodium crystal deposition. Volumetric analysis of atherosclerotic plaque demonstrated larger plaque volumes in gout patients with monosodium urate deposition (n=10) than matched gout patients without monosodium urate deposition (n=10) and matched control/non-gout patients (n=10) (p value of 0.03).

Conclusion:

  1. Dual energy CT is an effective tool to detect monosodium urate deposition in carotid arteries.
  2. Carotid arteries are not a common site for monosodium urate deposition but if present, can lead to increased atherosclerosis in the involved vessel.

Supporting image 2

Positive MSU carotid plaque on DECT


Disclosures: M. Sarfraz: None; L. Treanor: None; S. Nicolaou: None; A. Sheikh: None.

To cite this abstract in AMA style:

Sarfraz M, Treanor L, Nicolaou S, Sheikh A. Role of Dual-energy Computed Tomography (DECT) in Detection of Carotid Artery Monosodium Urate Deposition in Patients with Gout [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/role-of-dual-energy-computed-tomography-dect-in-detection-of-carotid-artery-monosodium-urate-deposition-in-patients-with-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-dual-energy-computed-tomography-dect-in-detection-of-carotid-artery-monosodium-urate-deposition-in-patients-with-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology